상세 정보

underline
Metadata Downloads : dc(xml) or Excel
Cited 0 time in scopus ci

Title 

In vivo neutralization of hepatitis B virus infection by an anti-preS1 humanized antibody in chimpanzees

Authors 

Hyo Jeong HongChun Jeih RyuHyang Suk HurS H KimH K OhM S OhS Y Park

Publisher 

Elsevier

Issue Date 

2004

Citation 

Virology, vol. 318, no. 1, pp. 134-141

Keywords 

chimpanzeehepatitis B virushumanized antibodyneutralizationpreS1antibody pre s1monoclonal antibodyneutralizing antibodydrug screening

Abstract 

Previously, we generated a murine monoclonal antibody (mAb), KR127, that recognizes amino acids (aa) 37-45 of the preS1 of hepatitis B virus (HBV). In this study, we have constructed a humanized version of KR127 and evaluated its HBV-neutralizing activity in chimpanzees. A study chimpanzee was given a single intravenous dose of the humanized antibody, followed by intravenous challenge with adr subtype of wild type HBV, while a control chimpanzee was only challenged with the virus. The result showed that the study chimpanzee did not develop HBV infection during 1 year, while the control chimpanzee was infected, indicating that the humanized antibody exhibited in vivo virus-neutralizing activity and thus protected the chimpanzee from HBV infection. In addition, the humanized antibody bound to the preS1 of all subtypes of HBV. We first demonstrate that an anti-preS1 mAb can neutralize HBV infection in vivo. This humanized antibody will be useful for the immunoprophylaxis of HBV infection.

ISSN 

0042-6822

Link 

http://dx.doi.org/10.1016/j.virol.2003.09.014

Appears in Collections

1. Journal Articles > Journal Articles

Registered Date

2019-05-02


There are no files associated with this item.
qrcode

FusionCharts.
DSpace Software Coptright(c) 2010 MIT and Hewleft-Packard  /  KRIBB-REPOSITORY ( Email:jakim@kribb.re.kr)